Skip to search.
 FTSE 100 Down 0.58%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
10.96 Up 0.29(2.72%) 27 Mar 20:00
|After Hours: : 10.94 Down 0.02 (0.19%) 27 Mar 20:06
Add to Portfolio
Prev Close:10.67
Open:10.73
Bid:10.25 x 300
Ask:11.10 x 100
1y Target Est:16.00
Beta:2.33
Earnings Date:4 May - 8 May (Est.)
Day's Range:10.72 - 11.20
52wk Range:1.77 - 13.20
Volume:1,547,117
Avg Vol (3m):1,909,940
Market Cap:1.05b
P/E (ttm):N/A
EPS (ttm):-0.93
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDUp 2.72%1.05b
SHPGUp 1.04%47.14b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):833.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.87
Quarterly EPS Est (Mar-15) :-0.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback